CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病预防

Abstract

Recommended Article

Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When When, where, and how to target vascular inflammation in the post-CANTOS era? MINOCA: a heterogenous group of conditions associated with myocardial damage Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic? CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes Endocardium Minimally Contributes to Coronary Endothelium in the Embryonic Ventricular Free Walls

Review Article2021 Mar 16;143(11):1157-1172.

JOURNAL:Circulation. Article Link

Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options

J Jankowski, J Floege, D Fliser et al. Keywords: chronic kidney disease; cardiovascular disease; pathophysiology; therapy

Full Text PDF